School of Medicine


Showing 101-162 of 162 Results

  • Judy Yang Pagtama, MSN, RN, FNP-C

    Judy Yang Pagtama, MSN, RN, FNP-C

    Affiliate, Medicine - Med/Oncology

    BioJudy Pagtama, MSN, RN, FNP-C is a nurse practitioner in thoracic oncology at the Stanford Cancer Center. She graduated with her Family Nurse Practitioner (FNP) degree from the University of California Los Angeles School of Nursing in 2009. Her area of clinical practice is thoracic oncology, specializing in lung cancer, thymic malignancies, and mesothelioma.

  • Minggui Pan, MD, PhD

    Minggui Pan, MD, PhD

    Clinical Professor, Medicine - Oncology

    BioDr. Pan is a board-certified, fellowship-trained medical oncologist with the Stanford Medicine Cancer Center and a clinical professor in the Department of Medicine, Division of Oncology.

    He diagnoses and treats various oncological conditions and specializes in the treatment of bone and soft tissue sarcoma. He creates personalized and comprehensive care plans for each patient he serves.

    Dr. Pan’s research focuses include understanding how genomic alterations impact the biological behavior and prognosis of sarcomas. In his work, he identifies new targets for developing innovative therapeutics for sarcoma treatment.

    He has published more than fifty papers and many abstracts and presented in many cancer and immunology conferences. His papers have been published in the Journal of Clinical Oncology, JCO Precision Oncology, Clinical Cancer Research, Nature Review Clinical Oncology, JCO Oncology Practice, Journal of Hematology and Oncology, and other peer-reviewed journals. He has also presented to his peers at international, national, and regional meetings, including the annual meetings of American Society of Clinical Oncology, Chinese Society Of Clinical Oncology, Connective Tissue Oncology Society and others.

    Dr. Pan is a member of American Society of Clinical Oncology, American Association of Immunologists, American Association for Advancement of Science, Society for Immunotherapy of Cancer, and Connective Tissue Oncology Society. Dr. Pan is also an adjunct investigator with Kaiser Permanente Division of Research.

  • Divya Parikh, MD

    Divya Parikh, MD

    Clinical Assistant Professor, Medicine - Oncology

    BioDr. Divya Parikh is board-certified in both medical oncology and internal medicine. She obtained her medical degree from Boston University School of Medicine and completed both her residency and fellowship through Stanford University. During her fellowship, she simultaneously earned a Master of Science in health policy from Stanford University.

    Dr. Parikh specializes in the care of patients with genitourinary cancers. In addition to her clinical responsibilities, she currently is a clinical assistant professor of medical oncology at Stanford School of Medicine. She mentors medical residents and fellows by sharing her insights, knowledge, and expertise.

    Dr. Parikh has a strong research background. She has published in multiple academic journals and presented her findings through poster and oral presentations at various medical conferences.

  • Mark Pegram

    Mark Pegram

    Susy Yuan-Huey Hung Professor

    Current Research and Scholarly InterestsMolecular mechanisms of targeted therapy resistance in breast and other cancers

  • Harlan Pinto

    Harlan Pinto

    Associate Professor of Medicine (Oncology) and of Otolaryngology - Head & Neck Surgery

    Current Research and Scholarly InterestsClinical Interests: general oncology, head and neck cancer Research Interests: chemoprevention trials and combined modality approaches to head and neck cancer

  • Kavitha Ramchandran

    Kavitha Ramchandran

    Clinical Professor, Medicine - Oncology

    Current Research and Scholarly InterestsMy research focuses on innovative models of care delivey to understand how to integrate primary and specialist palliative care. We also do work in palliative care education and how to scale our education to be impactful and sustainable. We are evaluating online models.

    In cancer care I do research on novel therapeutics in thoracic malignancies including immunotherapy, new targeted agents, and new sequencing of approved drugs.

  • Fauzia Riaz, M.D., M.H.S.

    Fauzia Riaz, M.D., M.H.S.

    Clinical Assistant Professor, Medicine - Oncology

    BioDr. Riaz is a medical oncologist specializing in breast cancer whose research focuses on novel therapeutics and approaches cancer care delivery for patients with breast cancer. She is currently a Clinical Assistant Professor in the Department of Medicine at Stanford University School of Medicine. Dr. Riaz completed formal research training during her fellowship, through Yale University’s Advanced Health Sciences Research program. This included training in biostatistics, research methodology, and health policy, ultimately culminating in the completion of a Master of Health Sciences. As faculty, she is an active member of the Stanford Breast Oncology Clinical Research Group, and currently serves as the Stanford site principal investigator and sub-investigator for several ongoing breast cancer clinical trials.

  • Sonia Rios-Ventura

    Sonia Rios-Ventura

    Family Health Navigator, Medicine - Med/Oncology

    BioSonia Rios-Ventura is a clinical research coordinator associate for the Stanford School of Medicine, department of Cancer Genetics and Genomics. She received her B.A. in anthropology and intensive sociology from the University of California Santa Cruz.

    She is also the family health navigator for the Genetic Information and Family Testing (GIFT) Study. GIFT's mission is to help families beat cancer. It aims to save lives through education and communication about cancer risk and prevention in families. When someone learns they have a genetic mutation that increases their risk for cancer, it means their family members might also be at risk. For too long, the difficult job of talking about family cancer risk has fallen to the cancer patients alone. GIFT is here to make it easier for people to share this important information and give family members an easy way to get genetic testing to learn about their personal cancer risk. GIFT is an online program developed by cancer patients, family members, and doctors that offers a new way to, 1. Share life-saving information about family cancer risk and ways to lower that risk, 2.Connect interested family members to easy, at-home genetic testing.

  • Rajat Rohatgi

    Rajat Rohatgi

    Professor of Biochemistry and of Medicine (Oncology)

    Current Research and Scholarly Intereststhe overall goal of my laboratory is to uncover new regulatory mechanisms in signaling systems, to understand how these mechanisms are damaged in disease states, and to devise new strategies to repair their function.

  • Mohana Roy, MD

    Mohana Roy, MD

    Clinical Assistant Professor, Medicine - Oncology

    BioDr. Roy is a medical oncologist and a clinical assistant professor in the Stanford University School of Medicine Department of Medicine, Division of Medical Oncology. She has expertise in Lung and Thoracic cancers, but with a broad clinical interest in hematology and oncology.

    Dr. Roy became an oncologist because of her passion for patient care. She is committed to being a clinician and is focused on improving the patient experience -- from the moment a patient checks in, to how information about their care is conveyed, and how the complex process of getting cancer care can be made a bit more seamless.

    Her research interests include access to clinical trials, quality improvement and improving care delivery. In that effort, she has published on work regarding patient reported outcomes (PROs) and their use to help clinical quality efforts- including in the context of a clinical trial with an electronic PRO portal, through distress screening with the Stanford Medicine Cancer Center, and in improving access to such screening and care for patient with limited English proficiency. She is the recipient of both a clinical innovation award through Stanford and an American Society of Clinical Oncology (ASCO) Merit award.

    She is the Associate Medical Director for Quality at Stanford Cancer Center from 2022.

    Dr. Roy received her medical degree from Albert Einstein College of Medicine, and then completed residency training at Beth Israel Deaconess Medical Center. She then completed fellowship training in Hematology and Oncology at Stanford. She was chief fellow for her graduating year during fellowship as well.

  • Anuja Anand Sathe

    Anuja Anand Sathe

    Instructor, Medicine - Oncology

    Current Research and Scholarly InterestsI am interested in understanding the determinants of therapeutic resistance in cancer. I investigate the composition of the tumor microenvironment and adaptive responses to therapy using single-cell and spatial approaches.

  • Lidia Schapira

    Lidia Schapira

    Professor of Medicine (Oncology)

    BioDr. Schapira is a medical oncologist with clinical expertise in the treatment of breast cancer. As the inaugural Director of Stanford's Cancer Survivorship Program, she has developed a thriving research and clinical program focused on optimizing health outcomes for people living with and beyond cancer. Dr. Schapira is interested in training future generations of physician-scientists as well as the broader community of practicing physicians through the design of innovative educational programs. Dr. Schapira's advocacy for people with cancer led to her appointment as Editor-in-Chief of the American Society of Clinical Oncology's website for the public,Cancer.Net, a position she held from 2015 until-2021. She served on the Board of Directors of the American Psychosocial Oncology Society and as Chair of the Psychosocial Interest Group of the Multinational Society for Supportive Care in Cancer. Dr. Schapira is particularily committed to reducing inequities in cancer outcomes and improve access to cancer care and cancer clinical trials. Dr. Schapira has published numerous manuscripts, lectures both nationally and internationally on issues of cancer survivorship and served as Associate Editor of the narrative section, Art of Oncology, for the Journal of Clinical Oncology from 2013 until 2023.

  • Joseph Schroers-Martin

    Joseph Schroers-Martin

    Assistant Professor of Medicine (Oncology)

    Current Research and Scholarly InterestsMedical heme/onc focused on molecular cancer diagnostics and novel biomarkers.

  • Arpeet Tarun Shah, MD

    Arpeet Tarun Shah, MD

    Affiliate, Medicine - Med/Oncology

    BioDr. Shah practices hematology and oncology. He has fellowship training in both specialties and is board-certified in hematology, oncology, and internal medicine.

    Dr. Shah is passionate about delivering patient-centered care. He aims to balance evidence-based treatments with each patient’s individual preferences. His goal is to maximize both clinical outcomes and quality of life.

    He feels privileged to have the opportunity to work so closely with patients and their families. Together, they can find and pursue what is important to them throughout their cancer journey.

    In addition to providing clinical care, Dr. Shah has conducted research. His research interests include molecular testing and immunotherapy outcomes in patients with non-small cell lung cancer (NSCLC).

    Dr. Shah has co-authored articles on treatment for NSCLC and other topics in publications such as Clinical Lung Cancer and Journal of Oncology Practice.

    He has made presentations to his peers at the American Society of Clinical Oncology–Society for the Immunotherapy of Cancer (ASCO-SITC) annual meeting and other conferences. He also has helped develop the curriculum and taught students in hematology, oncology, internal medicine, and neurobiology. In his hematology/oncology fellowship at Stanford, he was a senior teaching fellow.

    Dr. Shah was also a Johnson & Johnson Global Health Scholar, serving for two months as a visiting resident scholar in Kampala, Uganda.

    When not working, he enjoys reading, trying new recipes, and exploring parks with his family.

  • Sumit Shah

    Sumit Shah

    Clinical Associate Professor, Medicine - Oncology

    BioDr. Sumit Shah specializes in the management of advanced urologic malignancies such as prostate, kidney, bladder, and testicular cancers. He also serves as an investigator on numerous clinical trials, with a focus on novel immunotherapy agents. His academic interests also include digital health technologies and novel healthcare delivery services, both in the domestic and international setting. Dr. Shah graduated with distinction in biomedical engineering from Duke University, received his medical doctorate from Stanford University, and Masters in Public Health from Harvard University. He completed his internal medicine residency at the University of California, San Francisco (UCSF) where he stayed on faculty for one year before returning to Stanford for his fellowship training in medical oncology, where he now serves on the faculty.

  • Shagufta Shaheen

    Shagufta Shaheen

    Clinical Assistant Professor, Medicine - Oncology

    BioDr. Shaheen specializes in the gastrointestinal malignancies and she has expertise in treating neuroendocrine tumors (NETs). Following her fellowship in Hematology and Oncology, Dr Shaheen completed an advanced fellowship in Neuroendocrine tumors from Stanford University. The NET advanced fellowship is first of its kind in United State started under the leadership of Dr Pamela Kunz who is the founding Director of the Stanford Neuroendocrine Tumor Program established in 2015. After completing her advanced fellowship, Dr Shaheen joined Stanford Oncology division as Clinical Assistant Professor. Dr Shaheen is involved in further developing the neuroendocrine oncology program at Stanford which serves as a centre of excellence in the treatment of neuroendocrine tumors. Dr Shaheen is actively involved in clinical research and clinical trials. Dr Shaheen is also involved in taking care of patients admitted to the oncology service as well as resident and fellow teaching.

  • Anjali Sibley MD, MPH

    Anjali Sibley MD, MPH

    Clinical Associate Professor, Medicine - Oncology

    BioDr. Sibley is a Clinical Associate Professor of Medicine (Oncology) at Stanford School of Medicine. She is the Director of the Stanford Medicine Cancer Center in Emeryville and is a board-certified, fellowship-trained hematologist and medical oncologist.

    Her clinical interests include treating solid tumor cancers, lung cancers, blood cancers and benign blood conditions. She is interested in cancer prevention and reducing disparities in hematologic/oncologic care among underserved populations, and successful cancer survivorship programs.

    In addition to responsibilities related to patient care and overseeing the Cancer Center in Emeryville, Dr. Sibley has developed and is leading an innovative cancer survivorship clinic, including an exercise initiative. She also is passionate about advancing clinical trial enrollment for medically underserved populations and she serves on the Cancer Network’s East Bay Health Equity Committee leading lung cancer screening efforts in the East Bay. She is also working on a Stanford Cancer Institute-funded study examining psychosocial factors and cardiac health in Black cancer patients in the East Bay.

    She believes that providing patient care is a true privilege. Dr. Sibley utilizes a patient-centered practice approach that addresses multiple aspects of a patient’s well-being. Her research interests have included chemoprevention of breast cancer and the development of magnetic resonance imaging technology in breast cancer detection and mapping. She has also led community-based efforts to implement low-dose computed tomography (LDCT) as a screening tool for cancer.

    Dr. Sibley’s publications include articles on breast cancer prevention, breast magnetic resonance imaging, and other topics. Her work has appeared in American Journal of Hematology, JAMA, the Breast Journal, Internal Medicine News, and elsewhere. Dr. Sibley was invited to deliver a peer-reviewed presentation on community-based cancer screening and preventive education to the Global Health Council. Dr. Sibley is on the board of directors of the Cancer Support Community SF Bay Area. She has also served as a clinic physician for the Native American Health Center of Oakland, on the Committee on Health Equity of the American Public Health Association, and as chair and vice chair of the Cancer Forum Caucus of the American Public Health Association. She is a member of the American Society of Clinical Oncology, American Society of Preventive Oncology, and American Society of Hematology. She has provided volunteer services to the Global Health Council and to the Cancer Patients Aid Association, for whom she conducted a patient screening and education program in Mumbai, India.

  • Branimir I. Sikic, M. D.

    Branimir I. Sikic, M. D.

    Professor of Medicine (Oncology), Emeritus

    Current Research and Scholarly InterestsResearch Interests: cancer pharmacology, mechanisms of resistance to anticancer drugs, regulation and function of MDR1 and tubulin genes, CD47 as a target for activation of anticancer macrophases, Phase I trials of new drugs, gene expression profiling of cancers

  • Allyson Spence

    Allyson Spence

    Clinical Assistant Professor, Medicine - Oncology

    BioAllyson Spence MD, PhD is a Clinical Assistant Professor of Medicine in the Stanford University School of Medicine. She received her MD, PhD in the MSTP program at Vanderbilt University School of Medicine, studying basic mechanisms of transcription using Saccharomyces cerevisiae as a model system in the laboratory of Dr. Tony Weil. She went on to an internship and residency at the University of Pennsylvania before returning to Stanford to complete her Oncology fellowship training. She did a postdoctoral fellowship at Stanford in the department of Molecular Biology under the auspices of Dr. Margaret Fuller, where she was the recipient of a career award.

    She has transitioned from basic science research to clinical medicine where she sees patients diagnosed with breast cancer. Additionally, she has an appointment at the Palo Alto VA as a staff oncologist where she focuses on women's cancers and women at high risk of developing breast and gynecologic cancers. She is involved in several translational research projects at the VA, as well as being involved in clinical trials.

  • Sandy Srinivas

    Sandy Srinivas

    Professor of Medicine (Oncology) and, by courtesy, of Urology

    Current Research and Scholarly InterestsClinical interests: general oncology, genito-urinary malignancy Research interests: conducting clinical trials in advanced prostate cancer, bladder cancer and renal cell carcinoma

  • Frank E. Stockdale

    Frank E. Stockdale

    Maureen Lyles D'Ambrogio Professor in the School of Medicine, Emeritus

    Current Research and Scholarly InterestsLaboratory and clinical research in breast cancer ; Normal and abornal differentiation and growth

  • Samyuktha Suresh

    Samyuktha Suresh

    Postdoctoral Scholar, Oncology

    Current Research and Scholarly Interests- Exploring the crosstalk between DNA repair mechanisms and protein arginine methyltransferases in triple-negative breast cancer
    - Understanding the role of DNA repair enzymes in the context of breast cancer

  • Melinda L. Telli, M.D.

    Melinda L. Telli, M.D.

    Professor of Medicine (Oncology)

    Current Research and Scholarly InterestsMy research focuses on the development of novel therapies for the treatment of triple-negative and hereditary cancer. Other areas of interest include prevention of cardiac damage associated with breast cancer treatment and cardiotoxicity of anti-cancer agents.

  • Haluk Tezcan, MD

    Haluk Tezcan, MD

    Adjunct Clinical Associate Professor, Medicine - Oncology

    BioClinical focus:
    Breast Oncology
    Molecular Diagnostics

    Dr. Tezcan is a medical oncologist and hematologist with over three decades of diverse experience in cancer management and research.

    He is leading the development of Lexent Bio's liquid biopsy technology, first in response monitoring, overseeing scientific and clinical development of the technology. With over three decades of direct patient care and clinical trial experience as a principal investigator and director both in academia and private practice, he has firsthand understanding of unmet clinical needs of physicians and patients, and broad experience in clinical trial design and implementation.
    He established the CA.RE.foundation, a cancer research foundation dedicated to enabling clinical trial execution across community oncology sites throughout the Northwest US. He’s independently built multiple software tools to help oncologists in the practical realities of their daily work.

    Before Lexent Bio, he has served as Director of Translational Medicine at Genomic Health and as Vice President leading oncology development at Counsyl, integrating science with clinical product development. He is a steering committee member of the ASCO QOPI, a quality care initiative.

  • Heather Wakelee

    Heather Wakelee

    Winston Chen and Phyllis Huang Professor

    Current Research and Scholarly InterestsDr. Wakelee's research is focused on clinical trials and translational efforts in patients with lung cancer and other thoracic malignancies such as thymoma and thymic carcinoma. Other interests include translation projects in thoracic malignancies and collaborations with population scientists regarding lung cancer questions.